tiprankstipranks
HLB Life Science Co.,Ltd. (KR:067630)
:067630
South Korea Market
067630
HLB Life Science Co.,Ltd.
RESEARCH TOOLSreports

HLB Life Science Co.,Ltd. (067630) Financial Statements

― Followers

HLB Life Science Co.,Ltd. Financial Overview

HLB Life Science Co.,Ltd.'s market cap is currently ₩306.45B. The company's EPS TTM is ₩-876.55; its P/E ratio is -9.24; HLB Life Science Co.,Ltd. is scheduled to report earnings on August 7, 2026, and the estimated EPS forecast is ₩―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₩ 45.75B₩ 102.24B₩ 97.99B₩ 99.59B₩ 53.49B
Gross Profit₩ -494.41M₩ -2.19B₩ -748.57M₩ -3.05B₩ -5.54B
Operating Income₩ -21.02B₩ -24.82B₩ -24.53B₩ -20.16B₩ -18.48B
EBITDA₩ -83.58B₩ 25.87B₩ 22.84B₩ -45.75B₩ -49.88B
Net Income₩ -99.79B₩ 6.14B₩ -5.98B₩ -54.36B₩ -49.29B
Balance Sheet
Cash & Short-Term Investments₩ 13.88B₩ 79.57B₩ 78.86B₩ 131.44B₩ 139.96B
Total Assets₩ 478.09B₩ 539.02B₩ 423.50B₩ 411.79B₩ 270.80B
Total Debt₩ 160.36B₩ 123.78B₩ 166.58B₩ 147.47B₩ 4.62B
Net Debt₩ 147.07B₩ 71.06B₩ 149.81B₩ 116.49B₩ -26.63B
Total Liabilities₩ 180.35B₩ 140.19B₩ 192.29B₩ 175.72B₩ 24.19B
Stockholders' Equity₩ 297.35B₩ 398.34B₩ 230.80B₩ 234.72B₩ 246.19B
Cash Flow
Free Cash Flow₩ -48.88B₩ -59.47B₩ -31.54B₩ -41.40B₩ -16.69B
Operating Cash Flow₩ -22.93B₩ -32.01B₩ -10.02B₩ -29.74B₩ -14.08B
Investing Cash Flow₩ -34.63B₩ -37.78B₩ -8.88B₩ -72.64B₩ 8.82B
Financing Cash Flow₩ 18.26B₩ 105.74B₩ 4.79B₩ 102.10B₩ -641.09M
Currency in KRW

HLB Life Science Co.,Ltd. Earnings and Revenue History

Income Statement >

HLB Life Science Co.,Ltd. Debt to Assets

Balance Sheet >

HLB Life Science Co.,Ltd. Cash Flow

Cash Flow >

HLB Life Science Co.,Ltd. Forecast EPS vs Actual EPS

Earnings >